TIS11B Inhibitors

The class of TIS11B inhibitors, in the context of indirect inhibition, encompasses a diverse array of compounds that target various aspects of RNA synthesis, processing, and degradation. TIS11B, as a regulator of mRNA stability, is influenced by the cellular environment and the availability of its mRNA targets. Compounds like Actinomycin D, α-Amanitin, 5,6-Dichlorobenzimidazole, Ribavirin, DRB, and Mycophenolic Acid, which affect different stages of RNA synthesis and processing, can indirectly impact TIS11B's function. By inhibiting RNA polymerase activity or affecting nucleotide synthesis, these inhibitors can alter the pool of mRNAs that TIS11B regulates, consequently modulating its activity.

Moreover, compounds that influence protein synthesis and cellular signaling pathways, such as Rapamycin, Cycloheximide, Puromycin, and Leptomycin B, also belong to this class. Rapamycin, by inhibiting mTOR, can affect mRNA translation and stability, indirectly influencing TIS11B-regulated mRNA decay. Cycloheximide and Puromycin, known for their inhibition of protein synthesis, can disrupt the cellular environment and processes in which TIS11B is involved. Leptomycin B, affecting nuclear export, can also indirectly impact the regulation of mRNA by TIS11B. Chloroquine, affecting lysosomal degradation, represents another mechanism through which TIS11B function can be modulated.